AAAAAA

   
Results: 1-10 |
Results: 10
Treatment guidelines for acromegaly. Report from a Scandinavian workshop
Authors: Jorgensen, JOL Orskov, H Wass, J Astrup, J Bengtsson, BA Bjerre, P Bollerslev, J Christiansen, E Christiansen, JS Colao, AM Engstrom, BE Erfurth, EM Flogstad, AK Grenback, E Hagen, C Hoybye, C Landolt, AM Laurberg, P Schreiner, T Weeke, J
Citation: Jol. Jorgensen et al., Treatment guidelines for acromegaly. Report from a Scandinavian workshop, GROWTH H I, 11(2), 2001, pp. 72-74
Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo
Authors: Nielsen, S Mellemkjaer, S Rasmussen, LM Ledet, T Olsen, N Bojsen-Moller, M Astrup, J Weeke, J Jorgensen, JOL
Citation: S. Nielsen et al., Expression of somatostatin receptors on human pituitary adenomas in vivo and ex vivo, J ENDOC INV, 24(6), 2001, pp. 430-437
Incidence and late prognosis of Cushing's syndrome: A population-based study
Authors: Lindholm, J Juul, S Jorgensen, JOL Astrup, J Bjerre, P Feldt-Rasmussen, U Hagen, C Jorgensen, J Kosteljanetz, M Kristensen, LO Laurberg, P Schmidt, K Weeke, J
Citation: J. Lindholm et al., Incidence and late prognosis of Cushing's syndrome: A population-based study, J CLIN END, 86(1), 2001, pp. 117-123
Fractures in patients with primary idiopathic hypothyroidism
Authors: Vestergaard, P Weeke, J Hoeck, HC Nielsen, HC Rungby, J Rejnmark, L Laurberg, P Mosekilde, L
Citation: P. Vestergaard et al., Fractures in patients with primary idiopathic hypothyroidism, THYROID, 10(4), 2000, pp. 335-340
Fracture risk in patients treated for hyperthyroidism
Authors: Vestergaard, P Rejnmark, L Weeke, J Mosekilde, L
Citation: P. Vestergaard et al., Fracture risk in patients treated for hyperthyroidism, THYROID, 10(4), 2000, pp. 341-348
Occurrence and effects of octreotide antibodies during nasal, subcutaneousand slow release intramuscular treatment
Authors: Kaal, A Orskov, H Nielsen, S Pedroncelli, AM Lancranjan, I Marbach, P Weeke, J
Citation: A. Kaal et al., Occurrence and effects of octreotide antibodies during nasal, subcutaneousand slow release intramuscular treatment, EUR J ENDOC, 143(3), 2000, pp. 353-361
Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency
Authors: Skjaerbaek, C Frystyk, J Kaal, A Laursen, T Moller, J Weeke, J Jorgensen, JOL Christiansen, JS Orskov, H
Citation: C. Skjaerbaek et al., Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency, CLIN ENDOCR, 52(1), 2000, pp. 25-33
Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: Evidence of early beta-cell dysfunction
Authors: Nyholm, B Porksen, N Juhl, CB Gravholt, CH Butler, PC Weeke, J Veldhuis, JD Pincus, S Schmitz, O
Citation: B. Nyholm et al., Assessment of insulin secretion in relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus: Evidence of early beta-cell dysfunction, METABOLISM, 49(7), 2000, pp. 896-905
Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17 beta-estradiol and norethisterone
Authors: Gravholt, CH Klausen, IC Weeke, J Christiansen, JS
Citation: Ch. Gravholt et al., Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17 beta-estradiol and norethisterone, ATHEROSCLER, 150(1), 2000, pp. 201-208
Muscle mass and function in thyrotoxic patients before and during medical treatment
Authors: Norrelund, H Hove, KY Brems-Dalgaard, E Jurik, AG Nielsen, LP Nielsen, S Nielsen, S Jorgensen, JOL Weeke, J Moller, N
Citation: H. Norrelund et al., Muscle mass and function in thyrotoxic patients before and during medical treatment, CLIN ENDOCR, 51(6), 1999, pp. 693-699
Risultati: 1-10 |